Velo3D, Inc. Form 8-K Summary
Business Context and Reporting Period
Velo3D, Inc. filed this Current Report on January 4, 2024, regarding events occurring on December 28, 2023. The filing concerns the company’s continued listing status on the New York Stock Exchange (NYSE), not a financial reporting period.
Key Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes and Listing Status
- On December 28, 2023, Velo3D received formal notice from the NYSE that its common stock was not meeting the continued listing requirement under Section 802.01C of the NYSE Listed Company Manual.
- The deficiency resulted from the company’s average closing share price being below $1.00 over a consecutive 30-trading-day period.
- Velo3D plans to notify the NYSE of its intent to cure the deficiency.
- The company has six months from receipt of the notice to regain compliance with the minimum share price requirement.
- The notice has no immediate effect on the listing or trading of the common stock. The stock will remain listed during the cure period, subject to compliance with other NYSE requirements.
Outlook, Risks, and Unusual Items
Velo3D did not provide financial guidance or an operating outlook in this filing. Failure to regain compliance during the cure period, or failure to satisfy other NYSE continued listing requirements, could result in delisting. The filing states that the notice does not affect ongoing business operations or SEC reporting obligations.
On January 3, 2024, the company issued a press release regarding the NYSE notice, furnished as Exhibit 99.1. The filing was signed by Acting Chief Financial Officer Bernard Chung.
Facts Investors Should Verify
- The company’s plan and execution for restoring the average share price to at least $1.00.
- The applicable six-month cure-period deadline and any NYSE updates regarding compliance.
- Whether Velo3D remains compliant with all other NYSE continued listing standards.
- Any subsequent filing describing remediation actions, potential corporate actions, or delisting proceedings.